Literature DB >> 16956056

White-spot syndrome virus (WSSV) introduction into the Gulf of Mexico and Texas freshwater systems through imported, frozen bait-shrimp.

K W Hasson1, Y Fan, T Reisinger, J Venuti, P W Varner.   

Abstract

We analysed 20 boxes of, frozen imported bait-shrimp (China: Parapenaeopsis sp. and Metapenaeopsis sp.) and 8 boxes of native, frozen bait-shrimp (Gulf of Mexico: Litopenaeus setiferus and Farfantepenaeus duorarum) by RT-PCR or PCR for Taura syndrome virus (TSV), yellowhead virus/gill-associated virus (YHV/GAV), white-spot syndrome virus (WSSV) and infectious hypodermal and hematopoietic necrosis virus (IHHNV). All 28 boxes of shrimp were negative for TSV, YHV/GAV and IHHNV; 2 boxes of imported bait-shrimp were WSSV-positive by 3 different PCR assays. Intramuscular injection of replicate groups of SPF (specific pathogen-free) L. vannamei juveniles with 2 different tissue homogenates prepared from the 2 WSSV-positive bait boxes resulted in 100% mortality of the test shrimp within 48 to 72 h post-injection. No mortality occurred among injected negative control groups. Histological and in situ hybridization analyses of 20 moribund treatment-shrimp demonstrated severe WSSV infections in each sample. Oral exposure of SPF L. vannamei postlarvae, PL (PL 25 to 30 stage; approximately 0.02 g) to minced tissue prepared from the 2 WSSV-positive bait-lots did not induce infection, possibly because of an insufficient infectious dose and/or viral inactivation resulting from multiple freeze-thaw cycles of the bait-shrimp during PCR testing. Use of an electric drill and collection of drill-tailings (tissue from approximately 20 to 30 shrimp) from frozen blocks of shrimp was successfully employed as an alternate tissue-sampling method without thawing. Our findings indicate that imported WSSV-infected bait shrimp, originating from China, are being sold in Texas for the purpose of sport fishing and represent a potential threat to freshwater and marine crustacean fisheries, as well as to coastal US shrimp farms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956056     DOI: 10.3354/dao071091

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  8 in total

1.  White spot syndrome virus: an overview on an emergent concern.

Authors:  Arturo Sánchez-Paz
Journal:  Vet Res       Date:  2010-02-26       Impact factor: 3.683

2.  Per os infectivity of white spot syndrome virus (WSSV) in white-legged shrimp (Litopenaeus vannamei) and role of peritrophic membrane.

Authors:  Khuong Van Thuong; Vo Van Tuan; Wenfeng Li; Patrick Sorgeloos; Peter Bossier; Hans Nauwynck
Journal:  Vet Res       Date:  2016-02-29       Impact factor: 3.683

3.  Field-Usable Lateral Flow Immunoassay for the Rapid Detection of White Spot Syndrome Virus (WSSV).

Authors:  Prabir Kumar Kulabhusan; Jyutika M Rajwade; Vimal Sugumar; Gani Taju; A S Sahul Hameed; Kishore M Paknikar
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 4.  Viral disease emergence in shrimp aquaculture: origins, impact and the effectiveness of health management strategies.

Authors:  Peter J Walker; C V Mohan
Journal:  Rev Aquac       Date:  2009-05-15

Review 5.  Virus diseases of farmed shrimp in the Western Hemisphere (the Americas): a review.

Authors:  D V Lightner
Journal:  J Invertebr Pathol       Date:  2011-01       Impact factor: 2.841

6.  Synthesis and evaluation of polyamine carbon quantum dots (CQDs) in Litopenaeus vannamei as a therapeutic agent against WSSV.

Authors:  Huai-Ting Huang; Han-Jia Lin; Hui-Ju Huang; Chih-Ching Huang; John Han-You Lin; Li-Li Chen
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

7.  Bait effects in sampling coral reef fish assemblages with stereo-BRUVs.

Authors:  Stacey R Dorman; Euan S Harvey; Stephen J Newman
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 8.  Silver Nanoparticles as Potential Antiviral Agents.

Authors:  Zubair Ahmed Ratan; Fazla Rabbi Mashrur; Anisha Parsub Chhoan; Sadi Md Shahriar; Mohammad Faisal Haidere; Nusrat Jahan Runa; Sunggyu Kim; Dae-Hyuk Kweon; Hassan Hosseinzadeh; Jae Youl Cho
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.